Evidence map›Paper›PMID 32457109›Full record

ArticleAntimicrobial agents and chemotherapy2020

Chromosomal Resistance to Metronidazole in Clostridioides difficile Can Be Mediated by Epistasis between Iron Homeostasis and Oxidoreductases.

Aditi Deshpande, Xiaoqian Wu, Wenwen Huo, Kelli L Palmer, Julian G Hurdle

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Omadacycline andThe Annals of pharmacotherapy · 2023
    Pooled it
  2. Review
  3. Article
  4. The critical role ofApplied and environmental microbiology · 2026
    Article
  5. Biomedicines · 2025
    Review
  6. Microbiology spectrum · 2024
    Article
  7. Journal of bacteriology · 2024
    Article
  8. Article
  9. Pathogens (Basel, Switzerland) · 2024
    Review
  10. Antibiotic Resistances of Clostridioides difficile.Advances in experimental medicine and biology · 2024
    Article
  11. Article
  12. Antimicrobial Resistance ofInfection and drug resistance · 2024
    Article
  13. Journal of bacteriology · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Non-ToxigenicAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Make It LessGenes · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Aditi Deshpande *Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
Xiaoqian Wu *Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
Wenwen HuoDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, USA.
Kelli L PalmerDepartment of Biological Sciences, University of Texas at Dallas, Richardson, Texas, USA.ORCID 0000-0002-7343-9271
Julian G HurdleCenter for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA jhurdle@tamu.edu.
Texas A&M Health Science Center · USThe University of Texas at Dallas · USTufts University · US

Funding

Diversity Supplement: Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infectionR01AI139261 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Kevin W Garey, Julian G Hurdle · 2018 to 2026
$6.0M
Relationships Among Metronidazole Resistance, Pharmacodynamics and Treatment Outcomes in Clostridium difficile InfectionR56AI126881 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HURDLE, JULIAN G · 2017 to 2017
$608k
NIAID NIH HHS R01 AI139261NIAID NIH HHS R56 AI126881
6 · The paper itself

Abstract

Chromosomal resistance to metronidazole has emerged in clinical

Indexed as

Clostridioides difficileMetronidazoleOxidoreductasesClostridioidesDrug Resistance, BacterialEpistasis, GeneticHomeostasisIronIronMetronidazoleOxidoreductasesdrug resistance evolutioniron metabolismredox stress

Identifiers

PMID32457109
PMCPMC7526811
OpenAlexW3032575120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.